NFE2L2 and Alzheimer disease: Furthermore, ECH promoted Nrf2 via the PI3K/AKT signaling pathway against oxidative stress, inhibited TXNIP-NLRP3 interaction, reduced NLRP3 inflammasome against inflammation, and improved AD pathology (Fig. 7).